The MSLN gene, also known as Mesothelin, encodes a protein that plays a role in cell adhesion and differentiation. Mesothelin is primarily expressed in epithelial cells and is involved in the formation of adherens junctions, which are important for cell-cell adhesion and communication.
Mesothelin has been found to be overexpressed in various types of cancer, including pancreatic cancer and ovarian cancer. It has therefore become a target for diagnostic and therapeutic purposes. Monoclonal antibodies targeting mesothelin have been developed for the treatment of cancer.
The CHO-K1 cell line, derived from the kidney of a Chinese hamster, is a widely used cell line in research. It is known for its ability to grow in vitro and is often used for the production of recombinant proteins and the study of cellular metabolism.
In summary, the MSLN gene and its product, mesothelin, play a critical role in cell adhesion and differentiation and are important in the context of cancer diagnosis and treatment. The CHO-K1 cell line, on the other hand, is a valuable tool in research for the production and study of various cellular processes.
Mesothelin is a promising target in cancer therapy, particularly in pancreatic cancer, where its overexpression is linked to tumor progression and poor prognosis. The researchers in this study focused on understanding mesothelin's role by establishing cell lines that overexpress this protein, specifically CHO-K1-MSLN and PANC-1-MSLN. These cell lines were confirmed for mesothelin expression using Western blotting, providing a robust platform for testing novel therapeutics. In parallel, the development of a fully human anti-mesothelin antibody showcased innovative therapeutic potential. The researchers used phage display technology to screen from a naïve antibody library, identifying antibodies with high specificity for mesothelin. They evaluated the binding properties of these antibodies on the established cell lines, revealing that P1A6E and P3F2 exhibited significantly higher affinity compared to traditional antibodies like SS1 and C10. Flow cytometric analysis confirmed that these scFv proteins bound effectively to mesothelin-expressing cells, underscoring their potential utility in targeted therapies.
Figure 1. The researchers established MSLN-overexpressing cell lines, CHO-K1-MSLN and PANC-1-MSLN, to evaluate the binding properties of a fully human anti-mesothelin antibody. (Jiang H, et al., 2017)
Creative Biogene's Cas9 Stable Cell Line-CFPAC-1 offers researchers a valuable tool for studying gene editing and therapeutic applications involving mesothelin and other targets. By facilitating precise modifications, this cell line supports investigations into the molecular mechanisms of cancer and the development of innovative treatments. The ability to create stable, gene-edited cell lines enhances the accuracy and reliability of experimental outcomes, driving forward the research needed to tackle challenging cancers effectively.
The Monkey MSLN Stable CHO-K1 Cell Line has proven to be a significant asset in scientific research, clinical, and translational studies.
In scientific research, this cell line allows researchers to investigate the underlying mechanisms of MSLN’s role in cancer progression, metastasis, and drug resistance. It provides a valuable tool to explore the potential therapeutic strategies targeting MSLN, such as monoclonal antibody-based immunotherapy, small molecule inhibitors, and RNA interference techniques.
In the clinical setting, the Monkey MSLN Stable CHO-K1 Cell Line can be used to develop targeted therapies for patients with MSLN-expressing tumors. By understanding the functions and interactions of MSLN, researchers can identify new biomarkers for diagnosis, prognosis, and treatment response, improving personalized medicine approaches.
Translationally, this cell line enables the development of novel drug candidates and the assessment of their efficacy and safety in preclinical models. It also facilitates the understanding of drug resistance mechanisms, allowing for the optimization of treatment regimens.
In summary, the Monkey MSLN Stable CHO-K1 Cell Line is a valuable tool that is contributing to advancements in our understanding of cancer progression, the development of novel therapies, and the translation of research findings into clinical practice, ultimately improving patient outcomes.
Customer Q&As
What is the MSLN gene and its function?
A: The MSLN gene encodes for the mesothelin protein, which is a glycosylated cell surface protein primarily expressed by mesothelial cells. Mesothelin functions as a cell adhesion molecule and is involved in the regulation of cell proliferation and differentiation. It is also known to be overexpressed in certain cancers, such as mesothelioma and pancreatic cancer, making it a potential target for diagnostic and therapeutic strategies.
How does the MSLN gene contribute to cancer development?
A: The MSLN gene contributes to cancer development, particularly in mesothelioma and pancreatic cancer, by overexpression of the mesothelin protein. This overexpression can lead to aberrant cell adhesion, migration, and invasion, which are key processes in tumor progression and metastasis. Additionally, mesothelin can act as a tumor marker and facilitate the development of cancer-associated fibrosis.
Are there any therapeutic implications of targeting the MSLN gene?
A: Targeting the MSLN gene and its protein product has therapeutic implications for the treatment of cancers that overexpress mesothelin. Monoclonal antibodies, such as those directed against mesothelin, can be used to target and eliminate cancer cells. Additionally, mesothelin-targeted therapies may improve diagnostic methods and enhance the efficacy of immunotherapies.
How is the expression of the MSLN gene regulated in normal and cancerous cells?
A: The expression of the MSLN gene is regulated by various factors, including genetic alterations, oncogenic signaling, and environmental cues. In normal cells, mesothelin expression is confined to mesothelial cells. However, in cancerous cells, MSLN can become overexpressed due to genetic amplification or epigenetic changes, leading to increased mesothelin production and contributing to the pathogenesis of certain cancers.
Ask a Question
Customer Reviews
Legal and intellectual property
The Monkey MSLN Stable Cell Line - CHO-K1 complies with relevant laws and regulations regarding the use and distribution of animal cell lines. It also respects intellectual property rights, ensuring that researchers can use the cell line without infringing on any patents or copyrights.
United Kingdom
02/21/2021
Environmental impact
The use of animal cell lines like the Monkey MSLN Stable Cell Line - CHO-K1 can contribute to reducing the environmental impact associated with animal experimentation. By providing an alternative in vitro model, it helps minimize the use of laboratory animals, thereby reducing ethical concerns and the environmental footprint.
United Kingdom
04/09/2021
Social acceptance
The Monkey MSLN Stable Cell Line - CHO-K1 is generally well-accepted in the scientific community due to its relevance in research areas such as oncology and drug discovery. Its use aligns with the growing preference for more ethical and sustainable research practices, which is increasingly valued by society.
United Kingdom
01/02/2021
Data and validation
The Monkey MSLN Stable Cell Line - CHO-K1 is supported by comprehensive data and validation, including characterization of the cell line's phenotype, functional assays, and genetic stability. This ensures that researchers can trust the reliability and consistency of the cell line for their experiments.
Write a Review